David S Hong

67PUBLICATIONS
529CO-AUTHORS
Predictive and prognostic markersMolecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (67)

|Jun 04, 2026
Convergence of KRAS Mutations and MTAP Loss in Pancreatic Cancer: Genomic Landscape and Clinical Implications.

|May 06, 2026
<i>NTRK</i> Gene Fusions: A Compendium of Fusion Partners and Tumor Types.

|Mar 26, 2026
Comprehensive Genomic and Transcriptomic Analysis to Guide Therapy for Patients with Metastatic Solid Tumors.

Burak Uzunparmak, Fei Su, Amber Johnson

|Jan 20, 2026
Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2.

Niamh Coleman, Zihan Wei, A John Iafrate

|Jan 08, 2026
From Biology to Bedside: Challenges and Strategies in Developing Combination Cancer Therapies in Early-Phase Trials.

Niamh Coleman, R Donald Harvey, David S Hong

|Dec 22, 2025
Master Protocol Design With Hybrid Control for Efficient Early-Phase Trial Consolidation.

Alexander M Kaizer, Xiaojiang Zhan, Eric Baron

Pageof 12

Frequent Collaborators

14 joint publications

Vivek Subbiah

13 joint publications

Aung Naing

11 joint publications

Janku Filip

11 joint publications

Funda Meric-Bernstam